TITLE

Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptide (ANP)

AUTHOR(S)
Angus, R. M.; Millar, E. A.; Chalmers, G. W.; Thomson, N. C.
PUB. DATE
January 1996
SOURCE
Thorax;Jan1996, Vol. 51 Issue 1, p71
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66091961

 

Related Articles

  • Inhaled atrial natriuretic peptide and asthmatic airways. Hulks, Geoffrey; Thomson, Neil C. // BMJ: British Medical Journal (International Edition);5/2/92, Vol. 304 Issue 6835, p1156 

    Examines the bronchoprotective effect of inhaled atrial natriuretic peptide. Protection in the hyperreactive airway during inhalation; Use of autoradiography; Bronchodilator treatment for asthma.

  • Changes in A-type natriuretic peptide and its receptors induced by a neutral endopeptidase inhibitor in a rat model of sepsis. Shinzo Takamori; Hiroharu Mifune; Toshihiro Matsuo; Norman Kimura; Junichi Honda; Kazuo Shirouzu // Surgery Today;Feb2008, Vol. 38 Issue 2, p130 

    Abstract Purpose  Elevated plasma A-type natriuretic peptide (ANP) levels in sepsis cause fluid transfer into extravascular spaces. We investigated the changes in ANP concentrations and natriuretic peptide receptor (NPR) expression induced by thiorphan, a neutral endopeptidase (NEP)...

  • Urinary neutral endopeptidase 24.11 activity: Modulation by chronic salt loading. Aviv, Ricardo; Gurbanov, Konstantin; Hoffman, Aaron; Blumberg, Shmaryahu; Winaver, Joseph // Kidney International;Mar1995, Vol. 47 Issue 3, p855 

    Neutral endopeptidase (NEP) 24.11 is a zinc-metallopeptidase involved in the metabolism of several biologically active peptides including enkephalin, atrial natriuretic peptide, bradykinin, and endothelin. The enzyme is found in abundant amounts in the brush border of renal proximal epithelial...

  • 316. Increased renal neutral endopeptidase activity may be a factor in CHF progression. Knecht, M.; Pagel, I.; Langenickel, T. // Kidney;May/Jun2003, Vol. 12 Issue 3, p110 

    Objective: To elucidate the loss of natriuretic and diuretic properties of atrial natriuretic peptide (ANP) in congestive heart failure (CHF). Methodology: Activity, protein concentrations, mRNA, and immunostaining of neutral endopeptidase (NEP) in kidneys of different models of severe CHF in...

  • Induction of Myocardial Fibrosis and Hypertrophy by Natriuretic Peptides. Lijnen, Paul J.; Petrov, Victor V.; Fagard, Robert H. // Vascular Disease Prevention;Nov2004, Vol. 1 Issue 3, p175 

    The heart is a major site of natriuretic peptides (NP). Atrial and brain natriuretic peptide (ANP and BNP) are predominantly produced by atria and ventricles. C-Natriuretic peptide (CNP) is also found in heart tissue. ANP and BNP are produced by cardiomyocytes and fibroblasts. Cardiac...

  • Atrial natriuretic peptide in diabetic nephropathy. Robert Zietse; Weimar, Willem; Schalekamp, Maarten A. // Kidney International Supplement;Sep1997, Issue 60, pS-33 

    Investigates the atrial natriuretic peptide (ANP) in diabetic nephropathy. Derangement of glomerular barrier function; Imitation of the early effects of diabetes on the kidney through infusion with an ANP; Use of ANP diagnostically to identify the patients who will develop diabetic nephropathy.

  • Vasopeptidase inhibition: A new treatment approach for endothelial dysfunction. Quaschning, Thomas; Galle, Jan; Wanner, Christoph // Kidney International Supplement;May2003, Issue 84, p54 

    Vasopeptidase inhibition: A new treatment approach for endothelial dysfunction. Angiotensin-converting enzyme (ACE) inhibition is a well-established principle in the treatment of endothelial dysfunction. Numerous preclinical and clinical studies have clearly demonstrated the beneficial effects...

  • Vascular effects of natriuretic peptides in healthy men. Komarek, Marius; Bernheim, Alain; Schindler, Ruth; Steden, Renate; Kiowski, Wolfgang; Rocca, Hans Peter Brunner-La; Brunner-La Rocca, Hans Peter // Journal of Cardiovascular Pharmacology & Therapeutics;Dec2004, Vol. 9 Issue 4, p263 

    Background: Most effects of atrial (ANP) and B-type natriuretic peptide (BNP) result from stimulation of the guanylyl-cyclase type A receptor. Chronic elevation causes hyporesponsiveness to ANP, whereas BNP effects tend to be preserved, implying an additional pathway of action. We,...

  • Corin: a serine protease. Jianzhong Shen; Qingyu Wu // Kidney International;Jan2011, Vol. 79 Issue 1, p138 

    A letter to the editor is presented in response to an article related to the role of corin and atrial natriuretic peptide (ANP) in controlling sodium reabsorption in nephrotic syndrome.

  • Apparent B-type natriuretic peptide selectivity in the kidney due to differential processing. Kishimoto, Ichiro; Hamra, F Kent; Garbers, David L // Canadian Journal of Physiology & Pharmacology;Aug2001, Vol. 79 Issue 8, p715 

    Two natriuretic peptides, atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP), are found principally in the heart. In preliminary experiments with mouse kidney cells or slices, we found mouse BNP1-45 much more potent than ANP1-28 in causing elevations of cGMP (>50-fold). The...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics